Compare continuous glucose monitors

As of August 2026 we track 8 continuous glucose monitors available here, and the cheapest one you can buy without a prescription is the FreeStyle Libre 2 Plus at about £103.98 a month.

Compare continuous glucose monitors
DeviceWear timeReadingsAccuracy (MARD)AlarmsPrescriptionPrice per sensorMonthly costCost to tryCost, testing 4× a yearYearly cost
FreeStyle Libre 3 PlusAbbott15 daysevery 1 minNot publishedYesNot required£69.9915 days£139.98per month£69.9915 days£279.96per year£1,703.09per year
FreeStyle Libre 2 PlusAbbott15 daysevery 1 minNot publishedYesNot required£51.9915 days£103.98per month£51.9915 days£207.96per year£1,265.09per year
Dexcom G7Dexcom10 daysevery 5 min8.2%manufacturer studyYesNot required£51.2510 daysexcludes VAT£153.75per month£51.2510 days£205.00per year£1,870.63per year
Dexcom G6Dexcom10 daysevery 5 min10%independent studyYesRequiredNot publishedNot publishedNot publishedNot publishedNot published
Dexcom ONE+Dexcom10 daysevery 5 minNot publishedYesNot required£35.0010 daysexcludes VATNot published£35.0010 days£140.00per year£1,277.50per year
Accu-Chek SmartGuideRoche14 daysevery 5 minNot publishedYesNot requiredNot publishedNot publishedNot publishedNot publishedNot published
Medtronic SimpleraMedtronic7 daysevery 5 minNot publishedYesRequiredNot publishedNot publishedNot publishedNot publishedNot published
ZOEZOE14 daysevery 1 minNot publishedNoNot required£149.00one-off testNot published£149.0014 daysNot publishedNot published

Prices are shown as each seller lists them. Some exclude VAT and some do not, so compare the tax basis as well as the figure. Diabetes VAT relief may apply to some buyers and not others.

What does the accuracy figure mean?

MARD is the average gap between what the sensor says and what a laboratory blood test says, as a percentage. A 10% MARD means readings are off by about 10% on average — so a true 7.0 mmol/L might show as anywhere around 6.3 to 7.7. Lower is better. Most current sensors sit under 10%; twenty years ago they were over 20%. No sensor is exact, which is why treatment decisions still get confirmed with a fingerstick when a reading does not match how you feel.

Sources: Almurashi AM, Rodriguez E, Garg SK (2023). Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases. Journal of the Indian Institute of Science.